Clinical Trial Update: Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update describing novel regimens being studied for pulmonary tuberculosis; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Tuberculosis

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Pulmonary Tuberculosis | Phase 2 | Status: RECRUITING